Skyepharma Revenue, Profits - SKYEY Annual Income Statement

Add to My Stocks
$6.28 $0.02 (0.32%) SKYEY stock closing price Jun 24, 2016 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Skyepharma stock price alone is not sufficient. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the SKYEY stock is bound to reflect the impact of the YOY growth of 20.56%. Along with Skyepharma assets and Skyepharma free cash flow, Skyepharma profits as shown in profit and loss statement give key insights about the business. The net profit for 2015 is $40.21M and the 2015 revenue is $146.62M.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec20152014201320122011201020092008
Skyepharma Revenues or Net Sales
146.62M121.62M97.95M79.09M88.56M89.84M87.53M115.38M
Cost Of Goods Sold (COGS)65.89M54.22M51.95M33.12M34.97M21.8M23.48M36.35M
Skyepharma Gross Profit
80.72M67.4M46M45.96M53.58M68.03M64.04M79.02M
Research & Development Expense22.78M19.94M16.89M20.44M26.95M36.33M30.69M46.56M
Selling General & Admin Expense8.4M9.06M7.04M5.54M6.41M7.57M8.76M10.75M
Income Before Depreciation Depletion Amortization49.53M38.4M22.06M19.97M20.21M24.12M24.58M21.7M
Depreciation Depletion Amortization1.37M1.31M1.4M1.1M1.12M1.08M-1.29M
Non Operating Income--41.86M-0.15M-16.64M-1.76M6.03M-4.22M-72.53M
Interest Expense1.98M11.53M22.06M18.7M18.93M19.01M20.82M-
Skyepharma Pretax Income
46.63M-16.31M-1.56M-16.48M-1.6M10.05M-1.4M-52.12M
Provision for Income Taxes6.42M--2.81M----1.11M
MinorityInterest--------
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations40.21M-17.3M1.25M-16.8M-2.56M9.74M-2.19M-53.23M
Extraordinary Items & Discontinued Operations---9.82M----
Skyepharma Profit/ Loss (Net Income)
40.21M-17.3M1.25M-6.97M-2.56M9.74M-2.19M-53.23M
Average Shares used to compute Diluted EPS107M85.37M47.7M29.5M23.99M23.95M23.4M11.6M
Average Shares used to compute Basic EPS104.8M85.37M46.1M29.5M23.99M23.95M23.4M11.6M
Income Before Nonrecurring Items40.21M-17.3M1.25M--10.98M--0.29M
Income from Nonrecurring Items----7.48M-3.37M-1.24M-2.23M-41.71M
Skyepharma Earnings Per Share Basic Net
0.38-0.200.03-0.24-0.110.41-0.10-3.62
Skyepharma Earnings Per Share Diluted Net
0.38-0.200.03-0.24-0.110.24-0.10-3.62
EPS Diluted Before Nonrecurring Items0.38-0.200.030.020.030.290.00-0.03
Preferred Dividends Acc Pd--------
Dividends Common--------
Dividend Per Share Common0.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Before investing one should read a report on Skyepharma stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that SKYEY stock has a topline or revenue of $146.62M for 2015 as per this Skyepharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: Most businesses like Skyepharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the SKYEY income statement, one can check the Skyepharma historical stock prices to check how the price has moved with time.